ReviewFrontiers in immunology2013

The dark side of dendritic cells: development and exploitation of tolerogenic activity that favor tumor outgrowth and immune escape.

Barbara Seliger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.